ASTech Co., Ltd.
Financials
Valuation Metrics
ASTech Co., Ltd.'s Market Cap is ₩522B. At end of 2025 it was ₩1038B. Ranked #1746 of 2,421 in KR market (top 72%), #1059 of 1,640 on KOSDAQ (top 65%), #207 of 294 in Materials (top 70%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 52.20B KRW | KR#1,746/2,421 Sec#207/294 |
| Revenue | 19.46B KRW | KR#2,142/2,421 Sec#283/294 |
| Net Income | -6.69B KRW | KR—/2,421 Sec—/294 |
| Total Assets | 111.34B KRW | KR#1,691/2,421 Sec#229/294 |
| Net Assets | 65.42B KRW | KR#1,730/2,421 Sec#235/294 |
| Employees | 43 | KR#2,109/2,421 Sec#261/294 |
| Value | ||
| P/B | 0.80x | KR#1,262/2,421 Sec#206/294 |
| P/S | 2.68x | KR#1,942/2,421 Sec#274/294 |
| FCF Yield | -53.72% | KR—/2,421 Sec—/294 |
| Profitability | ||
| ROE | -10.23% | KR#1,945/2,421 Sec#260/294 |
| ROA | -6.01% | KR#1,977/2,421 Sec#264/294 |
| Op. Margin | -42.86% | KR#2,216/2,421 Sec#286/294 |
| Revenue Growth | -34.68% | KR#2,245/2,421 Sec#288/294 |
| Earnings Growth | -258.69% | KR#1,264/2,421 Sec#160/294 |
| Financial Health | ||
| Debt Ratio | 70.18% | KR#1,221/2,421 Sec#148/294 |
| Total Debt | 42.87B KRW | KR#1,061/2,421 Sec#170/294 |
| FCF | -28.04B KRW | KR#1,973/2,421 Sec#241/294 |
| Cash | 13.44B KRW | KR#1,507/2,421 Sec#186/294 |
| Current Ratio | 0.59x | KR#2,091/2,421 Sec#265/294 |
| Dividend | ||
| Div. Yield | 6.11% | KR#179/2,421 Sec#29/294 |
| Performance | ||
| 1Y Return | -61.97% | KR#2,231/2,421 Sec#275/294 |
| 1M Return | -10.99% | KR#2,135/2,421 Sec#261/294 |
| From 52W High | -64.63% | KR#2,022/2,421 Sec#266/294 |
| 1Y MDD | -64.58% | KR#1,725/2,421 Sec#244/294 |
| Trading | ||
| Volume | 6,994 shares | KR#2,036/2,421 Sec#225/294 |
| Trading Value | 56.3M KRW | KR#1,793/2,421 Sec#206/294 |
| Foreign Own. | 13.05% | KR#372/2,421 Sec#41/294 |
| Per Share | ||
| EPS | -1,038 KRW | KR—/2,421 Sec—/294 |
| BPS | 10,152 KRW | KR#988/2,421 Sec#151/294 |
Company Info
AESTEK, established in 2005, specializes in the production of chemical raw materials, particularly ultraviolet blocking agents, and received KOSDAQ listing approval in 2023. The company built its business foundation in 2008 by partnering with Samjin Pharmaceutical for technology transfer and material supply. AESTEK produces sunblock raw materials and pharmaceuticals, growing into a specialized materials, parts, and equipment company through technology development and patent acquisition. The company is headquartered in Seocheon-gun, Chungcheongnam-do.